0 followers
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Diana M. Brainard
QNB Bank
1 follower
Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem)
1 follower
Alvarez & Marsal
46 followers
4D Molecular Therapeutics
3 followers
The Boring Company
35 followers
Temu
27 followers
Pivot Bio
2 followers
Quantum-Si
2 followers
Jeeves
5 followers
Immunome
2 followers
Cytokinetics
11 followers
Explore companies